This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richardson, K. S. Articles by Zundel, W. Search for Related Content PubMed PubMed Citation Articles by Richardson, K. S. Articles by Zundel, W. Related Collections Cellular Pathobiology Cellular Pathobiology: DNA Damage and Stress Responses

---

Subject Review

The Emerging Role of the COP9 Signalosome in Cancer

Departments of Pharmacology and Toxicology and Radiation Oncology, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky

Requests for reprints: Wayne Zundel, University of Louisville School of Medicine, Baxter Research Building II, Room 204C, 580 South Preston Street, Louisville, KY 40202. Phone: 502-852-3445; Fax: 502-852-4649. E-mail: wz{at}bcc.louisville.edu

Abstract

In the last several years, multiple lines of evidence have suggested that the COP9 signalosome (CSN) plays a significant role in the regulation of multiple cancers and could be an attractive target for therapeutic intervention. First, the CSN plays a key role in the regulation of Cullin-containing ubiquitin E3 ligases that are central mediators of a variety of cellular functions essential during cancer progression. Second, several studies suggest that the individual subunits of the CSN, particularly CSN5, might regulate oncogenic and tumor suppressive functions independently of, or coordinately with, the CSN holocomplex. Thus, deregulation of CSN subunit function can have a dramatic effect on diverse cellular functions, including the maintenance of DNA fidelity, cell cycle control, DNA repair, angiogenesis, and microenvironmental homeostasis that are critical for tumor development. Additionally, clinical studies have suggested that the expression or localization of some CSN subunits correlate to disease progression or clinical outcome in a variety of tumor types. Although the study of CSN function in relation to tumor progression is in its infancy, this review will address current studies in relation to cancer initiation, progression, and potential for therapeutic intervention. (Mol Cancer Res 2005;3(12):645–53)

This article has been cited by other articles:

				P. Oren-Giladi, O. Krieger, B. A. Edgar, D. A. Chamovitz, and D. Segal Cop9 signalosome subunit 8 (CSN8) is essential for Drosophila development. Genes Cells, March 1, 2008; 13(3): 221 - 231. [Abstract] [Full Text] [PDF]

				C. Klijn, H. Holstege, J. de Ridder, X. Liu, M. Reinders, J. Jonkers, and L. Wessels Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data Nucleic Acids Res., February 2, 2008; 36(2): e13 - e13. [Abstract] [Full Text] [PDF]

				A. S. Adler, L. E. Littlepage, M. Lin, T. L.A. Kawahara, D. J. Wong, Z. Werb, and H. Y. Chang CSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression Cancer Res., January 15, 2008; 68(2): 506 - 515. [Abstract] [Full Text] [PDF]

				A. G. Schrum, D. Gil, E. P. Dopfer, D. L. Wiest, L. A. Turka, W. W. A. Schamel, and E. Palmer High-Sensitivity Detection and Quantitative Analysis of Native Protein-Protein Interactions and Multiprotein Complexes by Flow Cytometry Sci. Signal., June 5, 2007; 2007(389): pl2 - pl2. [Abstract] [Full Text] [PDF]

				Z. Ullah, M. S. Buckley, D. N. Arnosti, and R. W. Henry Retinoblastoma Protein Regulation by the COP9 Signalosome Mol. Biol. Cell, April 1, 2007; 18(4): 1179 - 1186. [Abstract] [Full Text] [PDF]

				G. Gusmaroli, P. Figueroa, G. Serino, and X. W. Deng Role of the MPN Subunits in COP9 Signalosome Assembly and Activity, and Their Regulatory Interaction with Arabidopsis Cullin3-Based E3 Ligases PLANT CELL, February 1, 2007; 19(2): 564 - 581. [Abstract] [Full Text] [PDF]

				M. Winner, A. C. Koong, B. E. Rendon, W. Zundel, and R. A. Mitchell Amplification of Tumor Hypoxic Responses by Macrophage Migration Inhibitory Factor-Dependent Hypoxia-Inducible Factor Stabilization Cancer Res., January 1, 2007; 67(1): 186 - 193. [Abstract] [Full Text] [PDF]

				S. Xiao, D. Li, H.-Q. Zhu, M.-G. Song, X.-R. Pan, P.-M. Jia, L.-L. Peng, A.-X. Dou, G.-Q. Chen, S.-J. Chen, et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins PNAS, October 31, 2006; 103(44): 16448 - 16453. [Abstract] [Full Text] [PDF]